In Part 2 of our COVID-19 provider impacts segment, Avalere experts from the Center for Healthcare Transformation will discuss the impacts of COVID-19 on healthcare provider performance specific to exemptions and waivers.

In Part 3 of the COVID-19 provider impacts segment, Avalere experts from the Center for Healthcare Transformation will discuss the impacts of COVID-19 on provider performance-based incentive programs.

In Part 1 of a three-part provider impacts segment, Avalere experts from the Center for Healthcare Transformation will discuss the provider impacts of COVID-19 on measures, specifically related to cardiovascular disease, diabetes, obstetrics and gynecology, and primary care disease management. 

On June 11, 2020, Avalere experts explored the future role of telehealth and how organizations can help shape and take advantage of its increased utilization.

On June 9, 2020, Avalere experts hosted a webinar to discuss new data analytics and health economics and outcomes research approaches for evaluating key value-based topics in healthcare, including novel curative therapy affordability and access, alternative payment models, and the increasingly important role of real-world evidence in healthcare decision-making. Tune in to hear the audio version of the webinar.

In the fourth episode of the Specialty Pharmacy Stakeholder Perspectives podcast series, Avalere is joined by Adam Hanauer, Associate Vice President at Humana Specialty Pharmacy, and Mark Sasala, Principal Business Analyst of Products at Creehan & Company, to discuss the outlook of specialty pharmacy with a focus on the environmental considerations and potential impacts of COVID-19.

In the third episode of the Specialty Pharmacy Stakeholder Perspectives podcast series, Avalere is joined by Dr. Colin Edgerton to discuss the specialty pharmacy dynamics with a focus on the provider outlook.

In the second episode of the Specialty Pharmacy Stakeholder Perspectives series, Avalere is joined by Marc Boutin, CEO of the National Health Council, discussing the specialty pharmacy dynamics with a focus on the patient perspective.

In the first episode of the Specialty Pharmacy Stakeholder Perspectives series, Avalere is joined by Joel Wright, CEO at AllianceRx and Ernie Shopes, SVP Products and Client Delivery at Creehan and Company, discussing the outlook for specialty pharmacy, including a focus on trends in the pipeline and overall landscape.

Avalere is committed to the continuous effort for shaping how patients receive care in oncology, during and after COVID-19. In the third episode of our Start Your Day with Avalere podcast series, Avalere's market access and health economics and analytics experts will discuss how healthcare stakeholders are translating clinical evidence to determinations on value.